Comparison of self-expanding vs balloon-expandable aortic valves.

Trial ID:
IRB-22-7882
Paul S. Teirstein, M.D., FACC
This study will compare the safety and performance of the Medtronic Evolut PRO/PRO+ self-expanding heart valve system to the Edwards SAPIEN 3/3 balloon-expandable Ultra heart valve system for transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis. Both devices are FDA approved and commercially available.
* Have severe aortic stenosis<br>* Be willing to return for all required post-procedure follow-up visits

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org